Hostname: page-component-76d6cb85b7-lcgwf Total loading time: 0 Render date: 2026-07-26T03:47:07.273Z Has data issue: false hasContentIssue false

Prognostic factors for idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy and intravenous steroids

Published online by Cambridge University Press:  05 December 2016

S Hosokawa*
Affiliation:
Department of Otorhinolaryngology/Head and Neck Surgery, Hamamatsu University School of Medicine, Japan
K Sugiyama
Affiliation:
Irie ENT Clinic, Shizuoka, Japan
G Takahashi
Affiliation:
Yamahoshi ENT Clinic, Hamamatsu, Japan
S Takebayashi
Affiliation:
Department of Otolaryngology, Shizuoka Saiseikai General Hospital, Japan
H Mineta
Affiliation:
Department of Otorhinolaryngology/Head and Neck Surgery, Hamamatsu University School of Medicine, Japan
*
Address for correspondence: Dr Seiji Hosokawa, Department of Otorhinolaryngology/Head and Neck Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka 431-3192, Japan Fax: +81 53 435 2253 E-mail: seijih@hama-med.ac.jp

Abstract

Objective:

This study evaluated the prognosis of idiopathic sudden sensorineural hearing loss when treated with hyperbaric oxygen therapy and intravenous steroids.

Methods:

The clinical data for 334 patients with idiopathic sudden sensorineural hearing loss treated by hyperbaric oxygen therapy and intravenous steroids at our hospital were retrospectively reviewed. These data included the initial averaged five-frequency hearing level, patient age, interval between onset of symptoms and treatment, vertigo as a complication, and co-existence of diabetes mellitus.

Results:

The overall improvement rate was 69.2 per cent, including better improvement (25.5 per cent), good improvement (21.0 per cent) and fair improvement (22.7 per cent).

Conclusion:

Hyperbaric oxygen therapy appears to confer a significant additional therapeutic benefit when used in combination with steroid therapy for idiopathic sudden sensorineural hearing loss. If performed early, hyperbaric oxygen therapy may bring about hearing improvement in many patients who are unresponsive to initial therapy.

Information

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable